Mindful Self-Compassion for Lung Cancer
Trial Summary
What is the purpose of this trial?
The goal of this pilot clinical trial is to test a disease-tailored, mindfulness-based intervention (Mindful Self-Compassion for Lung Cancer; MSC-LC) in adults diagnosed with lung cancer who are experiencing stigma. The current project seeks to: * Evaluate preliminary evidence for the feasibility, acceptability, and preliminary efficacy of MSC-LC in reducing stigma for adults with lung cancer, compared to a waitlist control condition * Elicit interventional impact not captured through quantitative measures with qualitative data from purposively sampled high responders and non-responders from the intervention condition Participants will randomized to either the MSC-LC intervention (a 10-week, virtually-delivered, group-based psychosocial intervention focused on the development of mindfulness and self-compassion skills) or to a waitlist control group that receives a referral to an NCI list of helpful mental health resources in their community. Researchers will compare the intervention and control groups to see if the MSC-LC intervention reduces lung cancer stigma and increases self-compassion.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are on antidepressant, anxiolytic, antipsychotic, or mood stabilizing medications, your dose should not have been changed in the 8 weeks before joining the study.
What data supports the effectiveness of the treatment Mindful Self-Compassion for Lung Cancer (MSC-LC)?
Research shows that mindfulness and self-compassion can help reduce psychological distress and improve communication in couples facing lung cancer. Additionally, mindfulness-based interventions have been found to reduce symptoms and promote positive psychological outcomes in cancer patients, suggesting potential benefits for those with lung cancer.12345
Is Mindful Self-Compassion safe for people with lung cancer?
How is the Mindful Self-Compassion treatment unique for lung cancer patients?
Mindful Self-Compassion for Lung Cancer (MSC-LC) is unique because it focuses on enhancing mindfulness and self-compassion skills, which can help reduce psychological distress and improve communication in patients and their partners. Unlike traditional medical treatments, this approach emphasizes mental and emotional well-being, potentially benefiting both the individual and their relationships.145910
Research Team
Timothy J Williamson, Ph.D., MPH
Principal Investigator
Loyola Marymount University
Eligibility Criteria
This trial is for adults with lung cancer who feel stigmatized because of their diagnosis. Participants will be randomly assigned to either learn mindfulness and self-compassion skills in a virtual group setting over 10 weeks or placed on a waitlist while receiving standard mental health resources.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Mindful Self-Compassion for Lung Cancer (MSC-LC) intervention, a 10-week, virtually-delivered, group-based psychosocial intervention focused on mindfulness and self-compassion skills
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Mindful Self-Compassion for Lung Cancer (MSC-LC)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loyola Marymount University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator